Strata Skin Sciences Inc (SSKN)
0.3936
+0.01
(+3.14%)
USD |
NASDAQ |
May 17, 16:00
0.3955
0.00 (0.00%)
After-Hours: 20:00
Strata Skin Sciences Enterprise Value: 22.06M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 22.06M |
| May 16, 2024 | 21.64M |
| May 15, 2024 | 22.99M |
| May 14, 2024 | 21.68M |
| May 13, 2024 | 21.73M |
| May 10, 2024 | 21.41M |
| May 09, 2024 | 21.62M |
| May 08, 2024 | 21.94M |
| May 07, 2024 | 22.65M |
| May 06, 2024 | 22.92M |
| May 03, 2024 | 22.88M |
| May 02, 2024 | 22.28M |
| May 01, 2024 | 22.64M |
| April 30, 2024 | 22.64M |
| April 29, 2024 | 23.34M |
| April 26, 2024 | 26.30M |
| April 25, 2024 | 26.81M |
| April 24, 2024 | 27.89M |
| April 23, 2024 | 27.19M |
| April 22, 2024 | 26.84M |
| April 19, 2024 | 27.37M |
| April 18, 2024 | 26.93M |
| April 17, 2024 | 26.58M |
| April 16, 2024 | 25.70M |
| April 15, 2024 | 24.56M |
| Date | Value |
|---|---|
| April 12, 2024 | 26.14M |
| April 11, 2024 | 26.72M |
| April 10, 2024 | 26.49M |
| April 09, 2024 | 24.91M |
| April 08, 2024 | 25.44M |
| April 05, 2024 | 25.76M |
| April 04, 2024 | 25.72M |
| April 03, 2024 | 23.69M |
| April 02, 2024 | 24.27M |
| April 01, 2024 | 22.28M |
| March 28, 2024 | 21.51M |
| March 27, 2024 | 23.86M |
| March 26, 2024 | 24.39M |
| March 25, 2024 | 25.44M |
| March 22, 2024 | 25.72M |
| March 21, 2024 | 25.26M |
| March 20, 2024 | 25.30M |
| March 19, 2024 | 25.10M |
| March 18, 2024 | 25.26M |
| March 15, 2024 | 25.40M |
| March 14, 2024 | 26.49M |
| March 13, 2024 | 25.81M |
| March 12, 2024 | 26.49M |
| March 11, 2024 | 27.19M |
| March 08, 2024 | 26.84M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
18.47M
Minimum
Nov 13 2023
87.60M
Maximum
Aug 02 2019
44.20M
Average
42.69M
Median
Dec 06 2021
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 817.27M |
| Retractable Technologies Inc | -14.98M |
| Xtant Medical Holdings Inc | 116.32M |
| Asensus Surgical Inc | 62.82M |
| Catheter Precision Inc | 2.999M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.794M |
| Revenue (Quarterly) | 8.689M |
| Total Expenses (Quarterly) | 9.846M |
| EPS Diluted (Quarterly) | -0.11 |
| Gross Profit Margin (Quarterly) | 55.25% |
| Profit Margin (Quarterly) | -43.66% |
| Earnings Yield | -78.76% |
| Normalized Earnings Yield | -55.57 |